BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

949 related articles for article (PubMed ID: 25574089)

  • 1. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line.
    Gock M; Mullins CS; Harnack C; Prall F; Ramer R; Göder A; Krämer OH; Klar E; Linnebacher M
    World J Gastroenterol; 2018 Sep; 24(33):3749-3759. PubMed ID: 30197480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.
    Gock M; Mullins CS; Bergner C; Prall F; Ramer R; Göder A; Krämer OH; Lange F; Krause BJ; Klar E; Linnebacher M
    World J Gastroenterol; 2018 Nov; 24(43):4880-4892. PubMed ID: 30487698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype.
    Maletzki C; Huehns M; Knapp P; Waukosin N; Klar E; Prall F; Linnebacher M
    PLoS One; 2015; 10(11):e0143194. PubMed ID: 26618628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas.
    Maletzki C; Stier S; Gruenert U; Gock M; Ostwald C; Prall F; Linnebacher M
    PLoS One; 2012; 7(12):e52485. PubMed ID: 23300683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification.
    Ostwald C; Linnebacher M; Weirich V; Prall F
    Int J Oncol; 2009 Aug; 35(2):321-7. PubMed ID: 19578746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP.
    Warth A; Kloor M; Schirmacher P; Bläker H
    Mod Pathol; 2011 Apr; 24(4):564-70. PubMed ID: 21297586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
    Bae JM; Cho NY; Kim TY; Kang GH
    Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular features of young-onset colorectal cancer.
    Ballester V; Rashtak S; Boardman L
    World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer-derived tumor spheroids retain the characteristics of original tumors.
    Lee SH; Hong JH; Park HK; Park JS; Kim BK; Lee JY; Jeong JY; Yoon GS; Inoue M; Choi GS; Lee IK
    Cancer Lett; 2015 Oct; 367(1):34-42. PubMed ID: 26185002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Line Models of Molecular Subtypes of Colorectal Cancer.
    Mooi JK; Luk IY; Mariadason JM
    Methods Mol Biol; 2018; 1765():3-26. PubMed ID: 29589298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    Boot A; Oosting J; van Eendenburg JDH; Kuppen PJK; Morreau H; van Wezel T
    PLoS One; 2017; 12(9):e0184900. PubMed ID: 28931069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer.
    Tentler JJ; Nallapareddy S; Tan AC; Spreafico A; Pitts TM; Morelli MP; Selby HM; Kachaeva MI; Flanigan SA; Kulikowski GN; Leong S; Arcaroli JJ; Messersmith WA; Eckhardt SG
    Mol Cancer Ther; 2010 Dec; 9(12):3351-62. PubMed ID: 20923857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.